Serum levels of natriuretic peptides in children with various types of loading conditions

Scandinavian Cardiovascular Journal

Volumn 43, Issue 3, 2009, Pages 187-193

  Eerola, Anneli ^a,b,c   Jokinen, Eero ^b   Pihkala, Jaana I ^b  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Children; Congenital heart defects; Natriuretic peptides

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; AMINO TERMINAL PROATRIOPEPTIDE; NATRIURETIC FACTOR; UNCLASSIFIED DRUG;

ADOLESCENT; AORTA COARCTATION; ARTICLE; CHILD; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM SEPTUM DEFECT; HEART LEFT VENTRICLE OVERLOAD; HEART LEFT VENTRICLE SIZE; HEART RIGHT VENTRICLE OVERLOAD; HEART VENTRICLE FUNCTION; HEART VENTRICLE SIZE; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; PATENT DUCTUS ARTERIOSUS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD;

ADOLESCENT; ATRIAL NATRIURETIC FACTOR; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ECHOCARDIOGRAPHY, THREE-DIMENSIONAL; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; MALE; MULIBREY NANISM; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; YOUNG ADULT;

EID: 67651089663     PISSN: 14017431     EISSN: 16512006     Source Type: Journal    
DOI: 10.1080/14017430802455841     Document Type: Article

References (25)

1. de Bold AJ, Ma KK, Zhang Y, de Bold ML, Bensimon M, Khoshbaten A. The physiological and pathophysiological modulation of the endocrine function of the heart. Can J Physiol Pharmacol. 2001;79:705-14.
2. Cea LB. Natriuretic peptide family: New aspects. Curr Med Chem Cardiovasc Hematol Agents. 2005;3:87-98.
3. Campbell M. Natural history of atrial septal defect. Br Heart J. 1970;32:820-6.
4. Veldtman GR, Freedom RM, Benson LN. Atrial septal defect. In: Freedom RM, Yoo S-J, Mikailian H, Williams WG, editors. The natural and modified history of congenital heart disease. Blackwell Publishing; 2004. p. 31-43.
5. Campbell M. Natural history of persistent ductus arteriosus. Br Heart J. 1968;30:4-13.
6. Benson L, McLaughlin P. Coarctation of the aorta. In: Freedom R, Yoo SJ, Mikailian H, Williams WG, editors. The natural and modified history of congenital heart disease. Blackwell Publishing; 2004. p. 251-75.
7. Avela K, Lipsanen-Nyman M, Idanheimo N, Seemanova E, Rosengren S, Makela TP, et al. Gene encoding a new RING-B-box-Coiled-coil protein is mutated in mulibrey nanism. Nat Genet. 2000;25:298-301.
8. Karlberg N, Jalanko H, Perheentupa J, Lipsanen-Nyman M. Mulibrey nanism: Clinical features and diagnostic criteria. J Med Genet. 2004;41:92-8.
9. Lipsanen-Nyman M, Perheentupa J, Rapola J, Sovijarvi A, Kupari M. Mulibrey heart disease: Clinical manifestations, long-term course, and results of pericardectomy in a series of 49 patients born before 1985. Circulation. 2003;107:2810-5.
10. Holmgren D, Westerlind A, Lundberg PA, Wahlander H. Increased plasma levels of natriuretic peptide type B and A in children with congenital heart defects with left compared with right ventricular volume overload or pressure overload. Clin Physiol Funct Imaging. 2005;25:263-9.
11. Kunii Y, Kamada M, Ohtsuki S, Araki T, Kataoka K, Kageyama M, et al. Plasma brain natriuretic peptide and the evaluation of volume overload in infants and children with congenital heart disease. Acta Med Okayama. 2003;57: 191-7.
12. Matsuoka S, Kurahashi Y, Miki Y, Miyao M, Yamazaki Y, Nishiuchi T, et al. Plasma atrial natriuretic peptide in patients with congenital heart diseases. Pediatrics. 1988;82:639-43.
13. Koch A, Zink S, Singer H. B-type natriuretic peptide in paediatric patients with congenital heart disease. Eur Heart J. 2006;27:861-6.
14. Kampmann C, Wiethoff CM, Wenzel A, Stolz G, Betancor M, Wippermann CF, et al. Normal values of M mode echocardiographic measurements of more than 2000 healthy infants and children in central Europe. Heart. 2000;83: 667-72.
15. Eerola A, Jokinen E, Boldt T, Pihkala J. The influence of percutaneous closure of patent ductus arteriosus on left ventricular size and function: A prospective study using two- and three-dimensional echocardiography and measurements of serum natriuretic peptides. J Am Coll Cardiol. 2006; 47:1060-6.
16. Hall C. NT-ProBNP: The mechanism behind the marker. J Card Fail. 2005;11:S81-3.
17. Munagala VK, Burnett JC, Jr, Redfield MM. The natriuretic peptides in cardiovascular medicine. Curr Probl Cardiol. 2004;29:707-69.
18. Weil J, Bidlingmaier F, Dohlemann C, Kuhnle U, Strom T, Lang RE. Comparison of plasma atrial natriuretic peptide levels in healthy children from birth to adolescence and in children with cardiac diseases. PediatrRes. 1986;20:1328-31.
19. Nir A, Bar-Oz B, Perles Z, Brooks R, Korach A, Rein AJ. N-terminal pro-B-type natriuretic peptide: Reference plasma levels from birth to adolescence. Elevated levels at birth and in infants and children with heart diseases. Acta Paediatr. 2004;93:603-7.
20. Bay M, Kirk V, Parner J, Hassager C, Nielsen H, Krogsgaard K, et al. NT-proBNP: A new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function. Heart. 2003;89:150-4.
21. Book WM, Hott BJ, McConnell M. B-type natriuretic peptide levels in adults with congenital heart disease and right ventricular failure. Am J Cardiol. 2005;95:545-6.
22. Gewillig M, Mertens L, Moerman P, Dumoulin M. Idiopathic restrictive cardiomyopathy in childhood. A diastolic disorder characterized by delayed relaxation. Eur Heart J. 1996;17:1413-20.
23. Westerlind A, Wahlander H, Lindstedt G, Lundberg PA, Holmgren D. Clinical signs of heart failure are associated with increased levels of natriuretic peptide types B and A in children with congenital heart defects or cardiomyopathy. Acta Paediatr. 2004;93:340-5.
24. Dzimiri N, Moorji A, Afrane B, Al-Halees Z. Differential regulation of atrial and brain natriuretic peptides and its implications for the management of left ventricular volume overload. Eur J Clin Invest. 2002;32:563-9.
25. Ozhan H, Albayrak S, Uzun H, Ordu S, Kaya A, Yazici M. Correlation of plasma B-type natriuretic peptide with shunt severity in patients with atrial or ventricular septal defect. Pediatr Cardiol. 2007;28:272-5.